All In MedTech

Device Trial Radar · NCT04542616

Baerveldt 350 vs Ahmed ClearPath 250 for the Treatment of Glaucoma

Outcomes Comparison Between Baerveldt 350 and Ahmed ClearPath 250 Tube Shunts for the Treatment of Glaucoma

Last checked: Nov 20, 2026Latest source record: Apr 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

80

Actual

Start

Aug 13, 2020

Primary completion

Jul 31, 2024

Study completion Jul 31, 2024

Sponsor

Lead sponsor
State University of New York at BuffaloAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 9, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To compare the safety and efficacy of Baerveldt 350 and Ahmed ClearPath 250 tube shunts in lowering IOP in glaucoma patients.

Conditions

  • Glaucoma

Interventions

  • Baerveldt 350 vs. Ahmed ClearPath 250 tube shunt implantationDevice

    Baerveldt 350 vs. Ahmed ClearPath 250 tube shunt implantation for the treatment of severe uncontrolled glaucoma.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Intraocular Pressure (IOP)Time frame: Baseline, Month 1, Month 3, Month 6, Month 12, Month 24

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Ira G. Ross Eye Institute

    Buffalo, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.